Detalhe da pesquisa
1.
Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality.
Int J Mol Sci
; 25(1)2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203593
2.
The lipid ties of α1-antitrypsin: Structural and functional aspects.
Cell Immunol
; 375: 104528, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468329
3.
Accelerated Wound Border Closure Using a Microemulsion Containing Non-Inhibitory Recombinant α1-Antitrypsin.
Int J Mol Sci
; 23(13)2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806370
4.
Differential signaling patterns of stimulated bone marrow-derived dendritic cells under α1-antitrypsin-enriched conditions.
Cell Immunol
; 361: 104281, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33453508
5.
MitoTimer-based high-content screen identifies two chemically-related benzothiophene derivatives that enhance basal mitophagy.
Biochem J
; 477(2): 461-475, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32003437
6.
Immunosuppressive Drugs Alter α1-Antitrypsin Production in Hepatocytes: Implications for Epithelial Gap Repair.
Biol Blood Marrow Transplant
; 26(4): 625-633, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899361
7.
Toll-like receptor 3 (TLR3) variant and NLRP12 mutation confer susceptibility to a complex clinical presentation.
Clin Immunol
; 212: 108249, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31445170
8.
Application of directed evolution and back-to-consensus algorithms to human alpha1-antitrypsin leads to diminished anti-protease activity and augmented anti-inflammatory activities.
Cell Immunol
; 355: 104135, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703529
9.
Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action.
Cell Immunol
; 356: 104177, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32795666
10.
Trauma-induced vestibular dysfunction: Possible functional repair under α1-antitrypsin-rich conditions.
Cell Immunol
; 356: 104150, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32823037
11.
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.
Blood
; 131(12): 1372-1379, 2018 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437593
12.
Endogenous α1-antitrypsin levels in the perilymphatic fluid correlates with severity of hearing loss.
Clin Otolaryngol
; 45(4): 495-499, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32246580
13.
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes.
Int J Mol Sci
; 20(23)2019 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31795482
14.
IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation.
J Immunol
; 195(4): 1705-12, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26157171
15.
Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.
J Pharmacol Exp Ther
; 359(3): 482-490, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821710
16.
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus.
Pediatr Diabetes
; 17(5): 351-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26073583
17.
Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
Proc Natl Acad Sci U S A
; 110(37): 15007-12, 2013 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23975926
18.
Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses.
J Infect Dis
; 211(9): 1489-98, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25389308
19.
Pancreatic ß-cell Na+ channels control global Ca2+ signaling and oxidative metabolism by inducing Na+ and Ca2+ responses that are propagated into mitochondria.
FASEB J
; 28(8): 3301-12, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24719357
20.
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.
Proc Natl Acad Sci U S A
; 109(2): 564-9, 2012 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203983